GEN - Genetic Engineering and Biotechnology News

Cell Line Development Has to Evolve

The growing emphasis on CLD is evident in market projections. The global cell line development market is expected to expand ...
mccormick.northwestern.edu

Making Downstream Process Development Realistic

Master of Biotechnology program (MBP) student Anita Huang looks back on her six-month internship at UCB in the United Kingdom and what she learned from the experience. In 2019, two students in ...
GEN

Accelerated Downstream Development of Viral Vectors

Gene therapy has emerged as a cutting-edge modality with transformative potential for treating a broad range of genetic disorders. Despite significant advancements, the purification and separation of ...
Nasdaq

Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001

TUSTIN, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to ...
Nasdaq

Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Process Development, Drug Substance ...

Argonaut’s Clinical Fill-Finish Capabilities to Complement Avid’s Upstream and Downstream Process Development and Biologics Manufacturing Services in Supporting Developers of Biologic Therapeutics ...
Seeking Alpha

Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business

New Laboratories Have Potential to Support an Additional $20 Million in Annual Process Development Revenue, Doubling Current Mammalian Cell Process Development Capacity Expansion to Cost Approximately ...

Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio

Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business · GlobeNewswire Inc. Darmstadt, Germany, April 01, ...
Business Wire

Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine | Business Wire

TAMPA, Fla. & TUSTIN, Calif.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) and Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), today announced that the companies have entered into a ...